NOBIVAC® INTRA-TRAC®3 INTRANASAL OFFERS ADVANTAGES OVER ORAL AND INJECTABLE VACCINES
*Dant JC, Waszgis B, LaFleur RL, Xu Z, Tarpey I. Duration of Immunity for an Oral Bordetella Bronchiseptica Vaccine. ISCAID Proceedings, Portland, OR, 2018.
A proven intranasal vaccine that provides triple protection against the agents implicated in the cause of tracheobronchitis (“canine cough”).
Canine Adenovirus 2, Canine Parainfluenza Virus (modified live viruses), Bordetella Bronchiseptica (avirulent live culture).
INDICATIONS:
This product has been shown to be effective for vaccination of healthy dogs 3 weeks of age or older against canine adenovirus type 2, canine parainfluenza virus and Bordetella bronchiseptica.
NOBIVAC® INTRA-TRAC®3 INTRANASAL OFFERS ADVANTAGES OVER ORAL AND INJECTABLE VACCINES
*Dant JC, Waszgis B, LaFleur RL, Xu Z, Tarpey I. Duration of Immunity for an Oral Bordetella Bronchiseptica Vaccine. ISCAID Proceedings, Portland, OR, 2018.
PROMOTES A STRONGER IGA RESPONSE THAN SUBCUTANEOUS VACCINATION16,17
No items to show.
Keep your clinic and staff informed and aware of diseases and outbreaks.
Infographic
When it comes to dogs in social environments, respiratory protection is essential. Use this conversation starter to discuss full respiratory protection with your clients.
Digital Assets
This vaccination season, use these ready-to-share posts to educate pet parents about the importance of full canine respiratory protection.
eBook
Tips and guidelines for your clinic to prevent and manage canine influenza.
No items to show.
References:
1. Data on file, Merck Animal Health.
14. Bey RF, Shade FJ, Goodnow RA, Johnson RC. Intranasal vaccination of dogs with live avirulent Bordetella bronchiseptica: correlation of serum agglutination titer and the formation of secretory IgA with protection against experimentally induced infectious tracheobronchitis. Am J Vet Res. 1981;42(7):1130–1132.
15. Lehr C, Jayappa H, Erskine J, Brown A, Sweeney D, Wasmoen T. Demonstration of 1-year of immunity for attenuated Bordetella bronchiseptica vaccines in dogs. Vet Ther. 2008;9(4):257–262.
16. Davis R, Jayappa H, Abdelmagid OY, Armstrong R, Sweeney D, Lehr C. Comparison of the mucosal immune response in dogs vaccinated with either an intranasal avirulent live culture or a subcutaneous antigen extract vaccine of Bordetella bronchiseptica. Vet Ther. 2007;8(1):32–40.
17. Information sheet: Canine: Infectious respiratory disease complex (aka “kennel cough”). UC Davis Koret Shelter Medicine Program website. Updated April 25, 2012. Available at: http://www.sheltermedicine.com/node/31. Accessed October 29, 2013.
18. Cohn LA, Reinero CR. Respiratory defenses in health and disease. Vet Clin Small Anim. 2007;37(5):845–860.
19. Greene CE, ed. Infectious Diseases of the Dog and Cat. 4th ed. St. Louis, MO: Elsevier; 2012.
56. AAHA Canine Vaccination Guidelines (Revised 2017). https://www.aaha.org/guidelines/canine_vaccination_guidelines/practice_vaccination.aspx. Accessed July 26, 2018.